1. A Phase II Trial of Escalated Dose Proton Radiotherapy with Elective Nodal Irradiation and Concomitant Chemotherapy for Patients with Unresectable, Borderline Resectable or Medically Inoperable Pancreatic Adenocarcinoma (PCG PAN009-18)

    Submitted by centretek on Sat, 10/15/2022 - 10:29
  2. Pilot Study of Neoantigen Profiling in Patients with Melanoma Treated with PD-1 Blockade

    Submitted by centretek on Sat, 10/15/2022 - 10:29
    Summary
    This research study is designed to better understand the molecular determinants of response to immunotherapies including pembrolizumab and nivolumab. We hope to learn the relevance of tumor neoantigens in the recognition of cancer cells by the immune system. The ultimate goal is to rank and filter these neoantigens and correlate with response to immunotherapies.
  3. Pragmatic Phase III Randomized Trial Of Proton Vs. Photon Therapy For Patients With Non-Metastatic Breast Cancer Receiving Comprehensive Nodal Radiation: A Radiotherapy Comparative Effectiveness (Radcomp) Consortium Trial (RTOG-3510)

    Submitted by centretek on Sat, 10/15/2022 - 10:29